Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer)
view all Clinical Trials
Overview
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤60%.
Contact
For more information about this trial or to inquire about eligibility, call the research office at 215-707-5340.